Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 301 M284 M298 M367 M477 M485 M 1.63 B Research & development —————— — Operating income 1.51 B1.54 B1.7 B1.64 B1.89 B2.12 B 7.35 B Non-Operating Income, Total ———6 M—— — Interest expense, net of interest capitalized 1.06 B1.09 B1.09 B1.07 B1.2 B1.33 B 4.69 B Non-Operating Income, excl. Interest Expenses ———-1.07 B—— — Unusual income/expense —————— — Pretax income 653 M638 M766 M631 M641 M896 M 2.93 B Equity in earnings —————— — Taxes 122 M96 M133 M108 M114 M165 M 520 M Non-controlling/minority interest 4 M6 M4 M4 M4 M4 M 16 M After tax other income/expense -4 M21 M58 M-4 M44 M— — Net income before discontinued operations 527 M536 M629 M519 M523 M727 M 2.4 B Discontinued operations —————— — Net income 527 M536 M629 M519 M523 M727 M 2.4 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 500 M509 M602 M476 M482 M686 M 2.25 B Basic earnings per share (Basic EPS) 0.340.350.410.310.260.34 1.32 Diluted earnings per share (Diluted EPS) 0.340.340.410.30.250.33 1.29 Average basic shares outstanding 1.45 B1.46 B1.46 B1.48 B1.87 B1.95 B — Diluted shares outstanding 1.48 B1.48 B1.48 B1.5 B1.9 B1.97 B — EBITDA 441 M462 M620 M611 M743 M890 M 2.86 B EBIT 426 M449 M605 M562 M699 M793 M 2.66 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 15 M13 M15 M49 M44 M97 M 205 M